Summary
A technique is presented for study of steady state kinetics of methadone using pulse labeling with deuterated methadone (d3) and mass fragmentography to measure both unlabeled and labeled methadone in blood. Seven subjects maintained on methadone for at least 10 months were admitted to a closed metabolic ward. The daily dose of unlabeled methadone (d0) was substituted by one dose of methadone-d3 and plasma levels of methadone-d0 and methadone-d3 were followed for 48 h using a precise (SD±5%) and sensitive (30 pmol/ml) mass fragmentographic technique. Plasma half-lives (t1/2) for both methadone-d0 and metadone-d3 were calculated from samples obtained 8–24 h following the dose of methadone-d3. The t1/2 of oral methadone-d3 was shorter (22±2 h) than that of methadone-d0 (52±20 h). The same pattern was observed after intravenous administration. The results indicate multiple pools of methadone in the body.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Inturrisi, C. E., Verebely, K.: Disposition of methadone in man after a single oral dose. Clin. Pharmacol. Ther.13, 923–930 (1972)
Inturrisi, C. E., Verebely, K.: The levels of methadone in the plasma in methadone maintenance. Clin. Pharmacol. Ther.13, 633–637 (1972)
Masten, L. W., Peterson, G. R., Burkhalter, A., Way, E. L.: Effect of oral administration of methadone on hepatic microsomal mixed function oxidase activity in mice. Life Sci.14, 1635–1640 (1974)
Misra, A. L., Mulé, S. J., Bloch, R., Vadlamani, N. L.: Physiological disposition and metabolism of levo-methadone-l3H in non-tolerant and tolerant rats. J. Pharmacol. Exp. Ther.185, 287–299 (1973)
Änggård, E., Gunne, L.-M., Holmstrand, J., McMahon, R. E., Sandberg, C.-G., Sullivan, H. R.: Disposition of methadone in methadone maintenance. Clin. Pharmacol. Ther.17, 258–266 (1975)
Verebely, K., Volavka, J., Mulé, S., Resnick, R.: Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment. Clin. Pharmacol. Ther.18, 180–190 (1975)
Holmstrand, J., Änggård, E., Gunne, L.-M.: Methadone maintenance: Plasma levels and therapeutic outcome. Clin. Pharmacol. Ther.23, 175–180 (1978)
Horns, W. H., Rado, M., Goldstein, A.: Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride. Clin. Pharmacol. Ther.17, 636–649 (1975)
Änggård, E., Lewander, T., Sjöqvist, B.: Determination of homovanillic acid turnover in man. Life Sci.,15, 111–122 (1975)
Änggård, E., Holmstrand, J., Gunne, L.-M., Sullivan, H. R., McMahon, R. E.: Use of deuterium labeled methadone to measure steady state pharmacokinetics during methadone maintenance treatment. Proc. 2nd Internat. Conf. Stable Isotopes, Oak Brook 1975
Sullivan, H. R., Marshall, F. J., McMahon, R. E., Änggård, E., Holmstrand, J., Gunne, L.-M.: Mass fragmentographic determination of unlabeled and deuterium labeled methadone in human plasma. Possibilities for measurements of steady state pharmacokinetics. Biomed. Mass. Spectrom.2, 197–200 (1975)
Dole, V. P., Kreek, M. J.: Methadone plasma level: Sustained by a reservoir of drug in tissue. Proc. Nat. Acad. Sci.70, 10 (1973)
Olsen, G. D., Wendel, H. A., Livermore, J. D., Leger, R. M., Lynn, R. K., Gerber, N.: Clinical effects and pharmacokinetics of racemic methadone and its optical isomers. Clin. Pharmacol. Ther.21, 147–157 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Änggård, E., Nilsson, M.I., Holmstrand, J. et al. Pharmacokinetics of methadone during maintenance therapy: Pulse labeling with deuterated methadone in the steady state. Eur J Clin Pharmacol 16, 53–57 (1979). https://doi.org/10.1007/BF00644967
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00644967